The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development

Non-alcoholic fatty liver disease (NAFLD) is comprised of a spectrum of liver injury ranging from excess fat accumulation in the liver (steatosis), to steatohepatitis (NASH), to its end stage of cirrhosis. A hallmark of NAFLD progression is the decline in function of hepatic mitochondria, although t...

Full description

Bibliographic Details
Main Authors: Rory P. Cunningham, Ryan D. Sheldon, R. Scott Rector
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2020.00767/full
_version_ 1818081208636014592
author Rory P. Cunningham
Rory P. Cunningham
Ryan D. Sheldon
R. Scott Rector
R. Scott Rector
R. Scott Rector
author_facet Rory P. Cunningham
Rory P. Cunningham
Ryan D. Sheldon
R. Scott Rector
R. Scott Rector
R. Scott Rector
author_sort Rory P. Cunningham
collection DOAJ
description Non-alcoholic fatty liver disease (NAFLD) is comprised of a spectrum of liver injury ranging from excess fat accumulation in the liver (steatosis), to steatohepatitis (NASH), to its end stage of cirrhosis. A hallmark of NAFLD progression is the decline in function of hepatic mitochondria, although the mechanisms remain unresolved. Given the important role endothelial nitric oxide synthase (eNOS) plays in mitochondrial dynamics in other tissues, it has emerged as a potential mediator of maintaining mitochondrial function in the liver. In this mini review, we summarize the most relevant findings that extends current understanding of eNOS as a regulator of mitochondrial biogenesis, and identifies a potential additional role in mitochondrial turnover and attenuating inflammation during NAFLD development and progression.
first_indexed 2024-12-10T19:02:33Z
format Article
id doaj.art-18ffd9a2db0a411ebf6cd936ef3b03c3
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-10T19:02:33Z
publishDate 2020-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-18ffd9a2db0a411ebf6cd936ef3b03c32022-12-22T01:36:57ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2020-07-011110.3389/fphys.2020.00767534770The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease DevelopmentRory P. Cunningham0Rory P. Cunningham1Ryan D. Sheldon2R. Scott Rector3R. Scott Rector4R. Scott Rector5Research Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, MO, United StatesDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO, United StatesMetabolic and Nutritional Programming, Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, United StatesResearch Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, MO, United StatesDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO, United StatesMedicine-Division of Gastroenterology and Hepatology, University of Missouri, Columbia, MO, United StatesNon-alcoholic fatty liver disease (NAFLD) is comprised of a spectrum of liver injury ranging from excess fat accumulation in the liver (steatosis), to steatohepatitis (NASH), to its end stage of cirrhosis. A hallmark of NAFLD progression is the decline in function of hepatic mitochondria, although the mechanisms remain unresolved. Given the important role endothelial nitric oxide synthase (eNOS) plays in mitochondrial dynamics in other tissues, it has emerged as a potential mediator of maintaining mitochondrial function in the liver. In this mini review, we summarize the most relevant findings that extends current understanding of eNOS as a regulator of mitochondrial biogenesis, and identifies a potential additional role in mitochondrial turnover and attenuating inflammation during NAFLD development and progression.https://www.frontiersin.org/article/10.3389/fphys.2020.00767/fulleNOSnitric oxidemitochondriaNAFLDNASH
spellingShingle Rory P. Cunningham
Rory P. Cunningham
Ryan D. Sheldon
R. Scott Rector
R. Scott Rector
R. Scott Rector
The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development
Frontiers in Physiology
eNOS
nitric oxide
mitochondria
NAFLD
NASH
title The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development
title_full The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development
title_fullStr The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development
title_full_unstemmed The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development
title_short The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development
title_sort emerging role of hepatocellular enos in non alcoholic fatty liver disease development
topic eNOS
nitric oxide
mitochondria
NAFLD
NASH
url https://www.frontiersin.org/article/10.3389/fphys.2020.00767/full
work_keys_str_mv AT rorypcunningham theemergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT rorypcunningham theemergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT ryandsheldon theemergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT rscottrector theemergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT rscottrector theemergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT rscottrector theemergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT rorypcunningham emergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT rorypcunningham emergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT ryandsheldon emergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT rscottrector emergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT rscottrector emergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment
AT rscottrector emergingroleofhepatocellularenosinnonalcoholicfattyliverdiseasedevelopment